SuperSonic Imagine Announces Its 2016 Financial Calendar
Get Alerts SSI Hot Sheet
Join SI Premium – FREE
AIX-EN-PROVENCE, France--(BUSINESS WIRE)-- Regulatory News:
SuperSonic Imagine (Paris: SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialized in ultrasound medical imaging, today announces its schedule for the publication of financial information for 2016.
| Event | Date * | |||
| 2015 Full-Year Sales | January 19, 2016 | |||
| 2015 Full-Year Results | March 14, 2016 | |||
| 2016 First-Quarter Sales | April 19, 2016 | |||
| Annual General Meeting | June 24, 2016 | |||
| 2016 First-Half Sales | July 19, 2016 | |||
| 2016 First-Half Results | September 12, 2016 | |||
| 2016 Third-Quarter Sales | October 18, 2016 | |||
| 2016 Full-Year Sales | January 17, 2017 |
* Subject to modification. Press releases are published after market closes.
About SuperSonic ImagineFounded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.
For more information about SuperSonic Imagine, please go to www.supersonicimagine.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160106005776/en/
SuperSonic Imagine
Marketing & Communication
Emmanuelle
Vella, +33 4 86 79 03 27
[email protected]
or
Blueprint
Life Science Group
Investor Relations - US
Candice Knoll,
+1 415 375 3340 Ext. 4
[email protected]
or
NewCap
Investor
Relations - EU
Pierre Laurent / Florent Alba
[email protected]
+33
1 44 71 98 55
Source: SuperSonic Imagine
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SEC clears JFB and XTEND merger path ahead of September close
- Matthews International names Michael Whitehead as new CEO
- The Estate Lawyers Announces Irvine Office Relocation to 3 Park Plaza
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Auriga, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share